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Abstract
Background: Posttraumatic Stress Disorder (PTSD) is more common in patients with Substance Use Disorder (SUD)
than in the general population. Although international guidelines recommend integrated treatment clinicians are
still hesitant in offering integrated treatment and more concrete recommendations are needed. This study aims to
contribute to a practice-based guideline through the exploration of practice-based decision criteria to determine
the indication and treatment of SUD and PTSD.
Methods: A vignette study to explore the views of experienced clinicians on the treatment of SUD and PTSD.
Results: Thirty-one experienced clinicians working in Dutch addiction care facilities filled in 15 vignettes resulting in
465 scored vignettes. Respondents did not report any contra-indications for integrated treatment and the perceived
relationship between SUD and PTSD was found to be an important factor in the indication of integrated treatment.
Conclusions: For integrated treatment to be offered to all eligible patients more training and schooling in trauma
treatment and comorbid psychopathology is needed for all disciplines involved. Inpatient treatment options are
necessary when patients need external support due to psychiatric or physical vulnerabilities. Further research into
the effect of the relationship between SUD and PTSD on treatment execution and effectiveness is needed and can
contribute to future treatment guidelines.
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Background
The comorbidity of Substance Use Disorder (SUD) and
Posttraumatic Stress Disorder (PTSD) is common and
internationally reported prevalence rates vary from 15%
[1] up to 52% [2]. In the Netherlands 17% [3] to 37% [4]
of patients entering an inpatient or outpatient addiction
treatment program have SUD and lifetime PTSD. For resi-
dential SUD treatment percentages are considerably
higher, e.g. 46.2% [5]. It is clear that PTSD is more com-
monly found in patients with substance use disorders than
in the general population, in which it is about 10% [4, 6].
There are several international guidelines that recom-
mend an integrated treatment of both disorders [7–10]
because of indicated better outcome than treatment in
which the disorders are treated separately [8–11]. Pa-
tients also prefer a simultaneous, integrated treatment
for both disorders [12, 13]. In practice, however, patients
often report separate treatment for each disorder. This is
supported by work completed by Najavitis [14], in which
clinicians rated integrated treatment of dual diagnosis
(SUD and PTSD) as more difficult to treat than either
disorder alone. Despite the guideline recommendations
and patient preferences PTSD seems greatly under-
treated in patients with SUD [8, 15–18].
Therapists working in addiction care are hesitant to
use an integrated treatment because they are afraid that
trauma-focused treatment will be harmful, counterpro-
ductive or that it will form a distraction from SUD treat-
ment [15]. Blakey and Bowers [19] found that
professionals in SUD treatment believed that an inte-
grated approach would take more time than was allo-
cated to them, and reported a lack of knowledge and
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absence of qualified professionals. Therapists also had
strong beliefs that addiction must be treated first be-
cause they viewed addiction to be the primary disorder
and thought abstinence a prerequisite for psychiatric
treatment. Furthermore, the historical separation be-
tween substance abuse treatment and mental health sys-
tems (with each system predominately focusing on just
one disorder) does not facilitate an integrated treatment
approach [19].
Research results on the topic of contra-indications are
somewhat inconsistent, giving little concrete support to
clinicians seeking guidance in treating this complex dual
diagnosis. In their review, Van Minnen et al. [20] con-
clude that substance use disorder is not a
contra-indication for trauma focused PTSD treatment.
Mills et al. [7] found that patients who received expos-
ure treatment for PTSD did not demonstrate poorer
substance use outcomes compared to patients who re-
ceived SUD treatment alone. However a more recent re-
view [21] suggests that there may be problems with
tolerability of trauma-focused intervention for some pa-
tients with SUD and PTSD due to more drop-out in pa-
tients receiving trauma-focused interventions.
Guidelines are not explicit in which patients should be
excluded from integrated treatment. It is possible that lack
of clarity when it comes to contra-indications makes clini-
cians overly careful and reserved in the administration of
integrated treatment. Research into integrated therapy for
patients with trauma and substance dependency often ex-
clude the following comorbidities: psychotic symptoms, sui-
cidal ideations and severe cognitive impairment [8, 22–26].
Recent research indicates that psychotic symptoms need
not be a contra-indication for the treatment of PTSD [27].
In addition to the psychiatric factors that may be viewed as
contra-indications there are contextual factors that are
often considered important preconditions. Safety, day struc-
ture, social support and stabilisation of substance use are
believed to be essential preconditions for trauma therapy
[28, 29]. Hospitalization or inpatient treatment can some-
times offer more safety, structure and support than can be
reached in outpatient treatment programs. However most
research to date has been done on outpatient populations.
Markus et al. [30] advise an outpatient setting where pos-
sible and an inpatient setting when needed, but does not
specify decision criteria. Another reason for hesitancy in
therapists is that they struggle with questions of when to
initiate trauma interventions and how to cope with
on-going substance use [12].
Recent research by (van Rens LW, Gielen N, Nass
GCM, Dijkstra BAG: Implementation of integrated treat-
ment for comorbid substance use disorder and posttrau-
matic stress disorder: a survey among clinicians in
Dutch addiction care, submitted) confirms the need for
concrete guidelines with respect to contra-indications
from the perspective of clinicians working in Dutch ad-
diction care. Although their view toward integrated
treatment is generally positive, it appears clinicians need
more guidance in the process of indicating or
contra-indicating PTSD treatment during addiction
treatment.
The present study uses patient vignettes to further
explore the views of experienced clinicians on the treat-
ment of SUD and PTSD in more depth resulting in
practice-based decision criteria to guide the indication
of integrated treatment of SUD and PTSD. Vignettes
are often used to identify decision making processes of
medical and paramedical professionals with respect to
diagnostics, needs assessment and treatment [31, 32].
The use of vignettes makes it possible to explore clini-
cian’s views accurately and realistically and reduces so-
cially desirable responses. Our main questions are 1)
Which psychiatric and contextual factors are taken into
account by experienced clinicians working in addiction
care when deciding if a patient should receive inte-
grated treatment for SUD and PTSD? and 2) Which
factors are taken into account when indicating treat-
ment setting? The results of this study provide guid-
ance for clinicians in the process of indicating and
contraindicating integrated treatment, and in the exe-
cution of integrated treatment.
Methods
Design and participants
A prospective vignette study was conducted among
healthcare and clinical psychologists working in addic-
tion care facilities in the Netherlands. Psychologists were
first approached in April and May of 2016 and again in
June and August of 2016 if there was no response. The
study protocol was approved by the institute’s internal
scientific committee. Participants participated in the
study voluntarily and they were guaranteed anonymity.
Procedures
Construction of vignettes
Psychologists working in addiction care facilities were
asked to provide researchers with patient cases. The
anonymized cases had to be based on a real patient with
at least a PTSD and SUD classification on the DSM-IV.
Psychologists were asked to state patient gender, all psy-
chiatric classifications according to the DSM-IV, actual
psychiatric state, previous psychiatric and/or addiction
treatment and the actual situation with respect to hous-
ing, work and relationships.
Psychologists provided 20 patient cases. Five cases
were excluded: one had no PTSD classification, the
other four were excluded due to overlap with other
cases. The remaining 15 cases were then poured into a
similar format, called the vignettes. To ensure anonymity
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the cases were altered. Yet alterations were kept to a
minimum to keep the vignettes realistic. The vignettes
represent the wide array of substances used by patients
in Dutch addiction care (e.g. alcohol (n = 10), cannabis
(n = 7), opiates (n = 1), amphetamines (n = 1), cocaine (n
= 2) and GHB (n = 2)) and the range in severity of symp-
toms associated with PTSD. They also include the var-
iety of comorbid symptoms and disorders often seen in
this population, like personality disorders (borderline
and antisocial features in particular), depression, psych-
otic symptoms, intellectual disabilities, suicidal tenden-
cies and cognitive dysfunctions. A short description of
the vignettes is found in Table 2.
Recruitment of respondents
Healthcare and clinical psychologists from the Van Rens
study (van Rens LW, Gielen N, Nass GCM, Dijkstra
BAG: Implementation of integrated treatment for co-
morbid substance use disorder and posttraumatic stress
disorder: a survey among clinicians in Dutch addiction
care, submitted) who indicated that they were willing to
take part in further research, were approached via
e-mail. Additionally, other psychologists working in
Dutch addiction care were approached through
snow-ball sampling. In snow-ball sampling the re-
searcher asks an already approached respondent to point
out possible new respondents. The new respondents
were then also approached via e-mail and asked to point
out possible new respondents. Non-responders were
sent a reminder mail. After this, non-responders were
asked one more time to complete the survey or to reply
that they were not willing or able to participate.
Of the 67 clinicians that were approached via mail
three indicated they had insufficient time to complete
the survey. One clinician indicated insufficient experi-
ence pertaining to the patient population and 29 did
not respond. Three were excluded afterwards due to
insufficient work experience with this population (less
than 2 years). Participants were informed twice via
e-mail and via the questionnaire about the goal of the
study, the extent of time and effort required, the ano-
nymity of results and the voluntary nature of partici-
pation. Thirty-one participants (a response rate of
46.3%) filled in 15 vignettes which resulted in 465
scored vignettes with a possible maximum of three
open answers (total maximum of 1395). The average
age of our sample of clinicians working in four differ-
ent addiction care facilities was 40.1 years (SD 8.6)
with an average of 7.2 years (SD 4.6) of work experi-
ence in PTSD treatment. The clinicians were mostly
healthcare psychologists (87.1%), ten of which were in
training to become specialists. Further participant
characteristics are summarized in Table 1.
Online survey vignettes: treatment recommendations
Respondents were issued a personal link to an online
survey containing the vignettes. They were asked A) to
which extent they would recommend integrated treat-
ment for SUD and PTSD for each vignette by grading
their decision on a visual analogue scale (VAS) with a
quantitative score from − 5 to + 5. A score of − 5 meant
that they were absolutely certain that they would not in-
dicate integrated treatment and + 5 meant that they were
absolutely certain that they would indicate integrated
treatment for the patient in that vignette. Respondents
were then invited to B) give three reasons for their deci-
sion. Following this they were asked which intervention
they would administer (detoxification, EMDR,
stabilization, cognitive therapy, exposure (imaginal and/
or in vivo and/or writing therapy and/or rescripting),
medicinal treatment, other intervention). These inter-
ventions were based on national and international
evidence-based guidelines for treatment of PTSD and
SUD [9, 33]. Respondents were requested to take the
most ideal situation in mind when making their treat-
ment indication decisions. That is independently of the
possibilities of the respondents’ workplace or the institu-
tion they work for.
Correspondingly respondents indicated C) whether
they would designate an outpatient or an inpatient
setting for each vignette. Again three reasons for this
decision could be given (D). For the first five vi-
gnettes they also specified E) impeding or facilitating
factors for the treatment that they recommended in
their own place of work. In contrast to step A to D,
step E is about the realistic scenario (e.g. own re-
sources and expertise) instead of the most ideal
situation.
Table 1 Demographic data of participating clinicians (n=31)
Age, mean (sd) 40.1 (8.6)
Work experience PTSD, mean (sd) 7.2 (4.6)
Profession, n (%)a
Psychologist 1 (3.2)
Health-care psychologist 27 (87.1)
Psychotherapist 3 (9.7)
Clinical psychologist 2 (6.5)
Clinical child, family and education studies 1 (3.2)
Level of care, n (%)b
Outpatient 21 (67.7)
Residential treatment 12 (38.7)
Day treatment 1 (3.2)
a3 participants are psychotherapists as well as health care psychologists
b1 participant works in all of the three level of care settings and 2 participants
work in a residential treatment setting as well as in an outpatient
treatment setting
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Determination of decision criteria
Based on the derived decision criteria (for further details
see data analysis), we formulated recommended criteria
for the indication of integrated treatment.
Data analysis
Data was processed and analysed using the Statistical
Package for the Social Sciences (SPSS), version 22. A de-
scriptive analysis of the respondents VAS score was car-
ried out per vignette. The percentage (frequency) of the
respondents scores within the range ≥ + 3 to + 5 (inte-
grated treatment of SUD and PTSD) or ≤ − 3 to − 5 (no
integrated treatment) was calculated for each vignette. A
percentage of 60 or higher within this range was consid-
ered to indicate an adequate level of consensus between
the respondents. To obtain the decision criteria for the
indication of integrated treatment interpretive recursive
abstraction qualitative analysis [34] was used by two re-
search psychologists (authors GN and LvR). The three
reasons given by all clinicians for and against the indica-
tion of integrated treatment were coded by each re-
search psychologist independently. After consensus was
reached 30 categories were determined. These were fur-
ther discussed and reduced to 25 categories. Following
this the categories were divided into three factors: psy-
chiatric factors, contextual factors and substance use fac-
tors. The decision criteria for in- or outpatient
treatment were obtained in the same way, as were im-
peding and facilitating factors given by clinicians in the
first five vignettes.
Results
Analysis of vignettes
The mean scores, standard deviation (SD) and range of
scores are shown per question for each vignette (Tables 2
and 3). Some vignettes showed that clinicians had op-
posite choices, with scores varying between − 5 and + 5.
In most vignettes the SD was relatively high, indicating
that the mean and SD were only partly informative. For
this reason the frequency scores were used.
Integrated treatment or not
For the choice of whether to recommend integrated
treatment or not 11 of the 15 vignettes had an adequate
level of consensus between the respondents (Table 2).
Deleting clinicians that made no indication choice (score
0) results in two extra vignettes (13 and 14) with an ad-
equate level of consensus. In all of the consensus vi-
gnettes clinicians recommended integrated treatment.
Decisive criteria for integrated treatment or not
The most commonly given reasons per consensus vi-
gnette are stated in Table 4. The interrelatedness of SUD
and PTSD is the reason most often given for the
indication of integrated treatment followed by the reason
that PTSD maintains SUD. The most often stated reason
for not recommending integrated treatment of SUD and
PTSD is the severity of SUD (i.e. substance use was in
remission).
Outpatient or inpatient setting
In three of 13 vignettes with a consensus for integrated
treatment clinicians were collectively convinced that in-
patient treatment was indicated. Outpatient treatment
was indicated for five vignettes. Deleting clinicians that
made no choice did not influence the results (Table 3).
Decision criteria for outpatient or inpatient setting
Table 5 shows the most commonly given reasons for the
eight vignettes in which there was an adequate level of
consensus, such as daytime activities and adequate sup-
port system for outpatient treatment; lack of support
system, suicide risk and susceptibility to crisis for in-
patient treatment.
Impeding or facilitating factors
The most frequently stated impeding factor for execut-
ing integrated treatment in their own place of work was
insufficient expertise. In many answers this pertained to
a lack of expertise in integrated treatment of SUD and
PTSD available in the work setting. However, insufficient
expertise in other comorbidities such as personality dis-
orders and cognitive impairment was also mentioned.
Not having the possibility to provide inpatient treatment
was also found to be an impeding factor as was not hav-
ing the possibility to offer (time) intensive treatment.
The most frequently mentioned facilitating factor was
the presence of sufficient expertise in the treatment of
PTSD.
Determination of decision criteria
Based on the results the following recommended criteria
for the indication of integrated treatment could be for-
mulated: the interrelatedness of SUD and PTSD, PTSD
maintains SUD, patients’ wishes, and the complexity of
comorbid psychopathology. For choice of setting the rec-
ommended criteria could be divided into three categor-
ies, namely psychiatric factors, contextual factors and
substance use factors. The criteria are shown in Table 6.
Discussion
This prospective vignette study was conducted in order
to contribute to a practice-based guideline in the treat-
ment of comorbid SUD and PTSD. The aim was to de-
termine practice-based decision criteria in the indication
of integrated treatment for patients with comorbid SUD
and PTSD and in the indication of treatment setting (in
or outpatient) when integrated treatment is indicated.
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In 86% of the presented cases an adequate level of
consensus was reached and integrated treatment was
recommended. The relationship between SUD and
PTSD was found to be the most important decision cri-
terion for the indication of integrated treatment. The de-
cision criteria for treatment setting, underlined the
Table 2 Descriptive results per vignette scored by clinicians (n = 31) on the indication of integrated treatment of SUD and PTSD
Vignette min max mean (SD) % ≤ − 3
no integrated
treatment
% ≥ + 3
integrated
treatment
% ≥ + 3 after filter
non- choosers (n)
1. Female, 45, cocaine, heroin, cannabis. Multiple traumatic events (sexual
abuse, rape and violence) and prostitution. Complex PTSD and BPD with
antisocial tendencies. Many social and contextual problems.
−4 5 3.2 (2.0) 3.2 71.1 73.3 (30)
2. Male, 33, alcohol and cannabis. Abused for many years by male babysitter.
PTSD and BPD, followed DGT. Has residence and a job. In debt, has a
limited social network
−3 5 2.8 (2.3) 3.2 64.6 69.0 (29)
3. Male, 23, excessive amounts of alcohol each weekend leading to amnesia
after seeing his friend fall to his death. Re-experiences the accident, feels
guilty. Lives with his girlfriend, has a job.
−4 5 3.3 (2.5) 6.4 77.4 82.8 (29)
4. Male, 59, alcohol, many clinical therapies. Periods of sobriety. PTSD, physical
and sexual abuse, intellectual disability. On sick leave, drinks after half past
five. Suicidal tendencies 3 weeks ago. Girlfriend, acquaintances drink.
0 5 3.8 (1.4) 0.0 77.5 80.0 (30)
5. Female, 25, cannabis, alcohol and GHB. Personality disorder NOS, PTSD.
Stepfather was violent and stepbrother was sexually inappropriate. Removed
from home at young age. Many different institutions and addresses. Several
suicide attempts, now anxiety, depression and trouble controlling emotions.
0 5 3.8 (1.7) 0.0 77.5 85.7 (28)
6. Female 55, social drinker until an armed robbery. Since then 2 bottles of
wine a day to lower anxiety and tension caused by the trauma. Married,
two daughters, works, exercises and makes music.
−3 5 3.6 (2.0) 3.3 74.3 82.1 (28)
7. Female, 61, alcohol and PTSD. Has a daughter from her father who abused her
and gave her alcohol. Daughter given up for adoption contacted patient 5 years
ago and alcohol consumption further increased. Partner and 2 adult children.
0 5 3.1 (1.6) 0.0 71.0 81.5 (27)
8. Female, 32, cannabis, abstinent for 5 months after treatment, chronic PTSD.
Labelled ‘untreatable’ during childhood. Despondency and negative self-
image. No work, friend abuse drugs.
−5 5 0.7 (3.5) 29.0 38.7 44.4 (27)
9. Female, 20, cannabis and cocaine, many traumatic experiences. Symptoms
consistent with PTSD and indications found for impaired personality
development, probably Clusters B (problems with regulation of emotions,
fragile self-image). No permanent address, no income.
−4 5 3.0 (2.5) 6.4 74.2 82.1 (28)
10. Female, 30, Turkish, cannabis dependency in remission after treatment. PTSD
and depression. Lives with sister, no social network. Suicidal in the past.
−4 5 1.1 (3.1) 16.2 35.5 39.3 (28)
11. Female, 31, GHB, complex PTSD and psychotic disorder NOS. Exhibits
borderline personality traits during long-term GHB use. Hospitalized several
times for GHB detox. Has her own home. Parents are supportive, are her
children’s guardians. Partner is supportive, but also uses GHB.
−4 5 2.7 (2.4) 3.2 61.4 76.0 (25)
12. Male, 20, Moroccan, alcohol, depressive symptoms, PTSD, latent suicidality
and borderline intellectual functioning. Homosexual orientation which his
culture does not accept and parents do not know about. Physically
abused by a group because of his sexuality. Lives with residential
guidance, dept., no daytime activities.
−4 5 2.9 (2.0) 3.2 67.7 75.0 (28)
13. Female, 52, alcohol and amphetamine, PTSD, psychotic disorder NOS and
cognitive disorders due to physical disorder. Is abstinent. Lives
independently with guidance, works on a care farm.
−4 5 2.3 (2.4) 6.4 58.0 66.7 (27)
14. Female, 66, alcohol use halved with Campral. Drinks since her ‘coming-out’
as a lesbian. Happy with her life. Suffers form anxiety and avoidance after
a car accident 10 years ago. Lives with partner, on sick leave from her job.
Fairly extensive social network.
−5 5 2.1 (2.9) 9.6 58.1 62.1 (29)
15. Male, 20, alcohol and cannabis. History of amphetamine dependency.
ADHD, stagnated emotional development and PTSD. Mandatory contact
with addiction care because of joyriding under the influence. Insecure
attachment in his upbringing and bullying, fundamentally insecure. Lives
in a sheltered housing project, has a partner.
−3 5 3.3 (1.8) 3.2 74.2 79.3 (29)
N.B. Numbers in bold indicate that the percentage of scores ≥ + 3 or ≤ − 3 was ≥60% (considering an adequate level of consensus between the respondents)
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necessity of stability of a patients’ psychiatric, SUD and
contextual (social and living) situation. Outpatient treat-
ment is preferred when there is stability in daily activ-
ities, housing and comorbid psychopathology. Inpatient
treatment appears to be indicated when patients need
external support due to vulnerability. This can include
vulnerability as a result of comorbid psychopathology,
drug of choice (particularly GHB use), but also due to
lack of a support system. The two most often mentioned
impeding factors for executing integrated treatment in
their own place of work were the absence of inpatient
treatment possibilities and lack of expertise. In the
non-consensus vignettes substance use was already in
remission. This may explain the lack of consensus: some
clinicians found SUD sufficiently treated and chose to
focus on PTSD-treatment alone, while other clinicians
Table 3 Descriptive results per vignette for in- or outpatient treatment scored by clinicians who were part of the consensus group
that indicated integrated treatment (score of ≥ + 3 on question 1, n = 13)
Vignette N clinicians min max mean (SD) ≤ − 3%a outpatient
setting
% ≤ − 3 after filter
non choosers (n)
≥ + 3%a inpatient
setting
% ≥ + 3 after filter
non choosers (n)
1 23 −3 5 1.4 (2.8) 13.0 14.6 (22) 47.8 50.0 (22)
2 20 −5 5 −2.8 (2.4) 70.0 77.8 (18) 4.8 5.6 (18)
3 24 −5 3 −3.6 (2.1) 70.9 77.3 (22) 4.2 4.5 (22)
4 24 0 5 3.4 (1.3) 0.0 0.0 (23) 79.1 82.6 (23)
5 25 −3 5 4.0 (1.8) 4.0 4.0 (25) 88.0 88.0 (25)
6 23 −5 0 −4.1 (1.2) 91.3 95.4 (22) 0.0 0.0 (22)
7 22 −5 4 −0.9 (3.0) 36.3 53.3 (15) 13.6 20.0 (15)
9 23 −5 5 2.4 (2.8) 8.6 10.0 (20) 69.5 80.0 (20)
11 19 −5 5 1.9 (2.5) 5.3 6.2 (16) 42.1 50.0 (16)
12 21 −5 4 −1.4 (3.1) 38.0 42.1 (19) 14.3 15.8 (19)
13 18 −5 5 −1.8 (3.5) 50.0 52.9 (17) 22.3 23.5 (17)
14 18 −5 4 −3.1 (2.5) 77.8 93.3 (15) 5.6 6.7 (15)
15 23 −5 2 −2.5 (2.0) 60.9 70.0 (20) 0.0 0.0 (20)
a Frequency percentage score per vignette: outpatient setting (from ≤ − 3 to −5) or inpatient setting (from ≥ + 3 to + 5)
N.B. Numbers in bold indicate that the percentage of scores ≥ + 3 or ≤ − 3 was ≥60% per vignette (considering an adequate level of consensus between
the respondents)
Table 4 Reasons given by clinicians for their recommendation of integrated treatment in consensus vignettes (n = 13)
Vignette No of clinicians with score + 1
to + 5 for integrated treatment
Most commonly cited reasons for integrated treatment
1 28 PTSD maintains SUD (17), interrelatedness PTSD and SUD (9)
2 25 Interrelatedness PTSD and SUD (10), PTSD maintains SUD (9), patient wishes (7), limited
SUD (6)
3 26 Interrelatedness PTSD and SUD (11), PTSD maintains SUD (9)
4 30 Interrelatedness PTSD and SUD (15), PTSD maintains SUD (8), patient wishes (6)
5 27 Interrelatedness PTSD and SUD (12), PTSD maintains SUD (6), complexity of PTSD (6),
complexity of co-morbid psychopathology (5)
6 26 Interrelatedness PTSD and SUD (13), PTSD maintains SUD (6), patient wishes (6)
7 26 Interrelatedness PTSD and SUD (15), PTSD maintains SUD (5), long duration of SUD (4)
9 24 PTSD maintains SUD (9), interrelatedness PTSD and SUD (7)
11 23 Interrelatedness PTSD and SUD (6), severity of SUD (5), complexity of co-morbid
psychopathology (5)
12 26 Interrelatedness PTSD and SUD (8), PTSD maintains SUD (4), complexity of co-morbid
psychopathology, single-event trauma (4)
13 23 Interrelatedness PTSD and SUD (5), severity of SUD (5), level of suffering (4), PTSD maintains SUD (3),
complexity of co-morbid psychopathology (3)
14 23 severity of SUD (6), Interrelatedness PTSD and SUD (5), patient wishes (4), PTSD maintains SUD (4)
15 27 Interrelatedness PTSD and SUD (10), PTSD maintains SUD (7), complexity of co-morbid psychopathology
(5), patient wishes (4)
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advised continuation of treatment of both SUD and
PTSD. We do not consider this as a contra-indication
for integrated treatment, but as the absence of indication
for integrated treatment.
The use of vignettes in this study made it possible to
explore the views of experienced clinicians more realis-
tically than the use of questionnaires. Vignettes reduce
socially desirable responses and reflect clinical complex-
ity [35]. In our study we specifically asked experienced
clinicians to take the most ideal situation in mind, inde-
pendent from their workplace possibilities. We found
that a vast majority of respondents preferred integrated
treatment of SUD and PTSD. Noteworthy is that the
present study found the underlying reason for this pref-
erence to be the clinicians’ opinion that PTSD maintains
SUD. This is in line with research findings [36, 37]
which suggest that PTSD patients use drugs to
self-medicate for PTSD symptoms. Brown and Wolfe
[38] pose that the development of SUD may be a func-
tion of the stressor experienced. An alternative explan-
ation for the relationship between SUD and PTSD is
that problematic substance use increases the risk of ex-
posure to traumatic events, but research findings are in-
consistent [39]. Besides these causal models the shared
liability model proposes that both disorders share com-
mon risk factors such as genetic risk and personality
traits [2, 39]. Patients often perceive the two disorders to
be functionally related and prefer integrated treatment
[15].
Strikingly, in our study experienced clinicians did not
report contra-indications for integrated treatment, even in
vignettes in which there was high problem complexity and
complex comorbid psychopathology. This is in contrast to
results found in studies by Becker et al. [40] and Hagen-
aars et al. [41] in which clinicians found depression, sui-
cidality, dissociation, psychosis and comorbid anxiety
disorders to be contra-indications. Our findings may be
the result of our instruction to keep an ideal situation in
mind, but also the use of vignettes makes it more realistic.
Problem complexity and complexity of comorbid psycho-
pathology were only found to be important with respect
to deciding treatment setting and not for deciding inte-
grated treatment. From this, it is not surprising that a lack
of inpatient treatment possibilities was a frequently men-
tioned impeding factor for executing integrated treatment
in their own place of work. The absence of clinical beds
can result in a more reserved approach in the indication
of integrated treatment of SUD and PTDS. Besides the
possibility of inpatient treatment, clinicians also stress the
importance of appropriate schooling and training for ther-
apists and other disciplines in both trauma treatment and
comorbid psychopathology, both in inpatient and out-
patient settings. Clinicians need to be able to intensify out-
patient support or outpatient treatment if necessary. This
requires a sufficient amount of care workers and thera-
pists with adequate expertise. A perceived lack of expertise
can result in reluctance to indicate integrated treatment.
One limitation of the present study is that the recruit-
ment procedure may have contributed to selection bias.
Clinicians interested in integrated treatment or with a
Table 5 Reasons given by clinicians for their choice of treatment setting for vignettes in which there was consensus as to
integrated treatment and treatment setting (n = 8)
Vignette No of clinicians Choice of setting Most commonly cited reasons (n)
2 17 Outpatient Daytime activities (13), patient stability (8), adequate support system (7), limited SUD (6),
earlier treatment (5)
3 21 Outpatient Daytime activities (12), limited SUD (11), adequate support system (6)
4 23 Inpatient Suicide risk (14), severity of SUD (13), lack of support system (13)
5 24 Inpatient Drug of choice (13), suicide risk (11), vulnerability to psychosis (6), susceptibility to crisis (6),
lack of support system (5)
6 22 Outpatient Adequate support system (15), daytime activities (12), limited SUD (5), patient stability (5)
9 17 Inpatient Housing situation (15), susceptibility to crises (9), lack of support system (4)
14 14 Outpatient Adequate support system (11), single-event trauma (5), limited SUD (5)
15 18 Outpatient Adequate support system (17), housing situation (3)
Table 6 Recommended criteria for indication of in- or
outpatient setting for the integrated treatment of SUD and
PTSD
Criteria outpatient Criteria inpatient
Substance abuse Substance abuse
Limited SUD Severity of SUD
Drug of choice
Psychiatric Psychiatric
Patient stability Suicide risk
Earlier treatment Vulnerability to psychosis
Single-event trauma Susceptibility to crisis
Contextual Contextual
Daytime activities Lack of support system
Adequate support system Inadequate Housing situation
Stable Housing situation
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strong belief in integrated treatment may have been
more inclined to take part in the study. However this
was the target group we wanted to include because of
their expertise on the subject. Also respondents were all
working in Dutch addiction care which limits
generalization beyond addiction care and beyond Dutch
borders. EMDR, for example is an intervention in which
most psychologists working in the Netherlands are
trained. These Dutch therapists often feel better
equipped to treat PTSD with EMDR than with exposure.
This may however not be the case in other countries. As
written before we would like to emphasize that indica-
tion for integrated treatment, as reported by the respon-
dents, does not reliably reflect the actual usage of
integrated treatment. A merit of the study is the use of a
large number of vignettes which made it possible to gen-
erate a large response. Furthermore the vignettes were
well constructed as we found psychiatric, addiction and
contextual factors in the reasons given. A replica study
in a sample of non-experienced clinicians to investigate
whether they recommend integrated treatment or not is
recommended, the same applies for a replica study in
PTSD setting.
Present results emphasize the importance of appropri-
ate training and education for therapists administrating
integrated treatment and for other disciplines involved.
Furthermore the support and safety-net of inpatient
treatment possibilities can help clinicians in their deci-
sion to offer more vulnerable patients the guideline ad-
vised treatment for SUD and PTSD. Our findings stress
the importance of future studies on the relationship be-
tween SUD and PTSD. It is not unthinkable that inte-
grated treatment may be more effective in patients who
have a strong conviction that both disorders are related.
Current guidelines recommend integrated treatment,
but some research indicates that treatment effects vary
[21, 24]. Research into the effects of patients’ beliefs or
clinicians’ opinions about interrelatedness on the (out-
come of) treatment of PTSD in patients with SUD can
help to explain different treatment effects and offer fur-
ther contribution to practice based guidelines.
Conclusion
In conclusion, experienced clinicians did not report
contra-indications for integrated treatment of SUD and
PTSD, so integrated treatment should be offered when
comorbid SUD and PTSD is present. When integrated
treatment was not indicated substance use was already
in remission. We do not consider this as a
contra-indication for integrated treatment, but as the ab-
sence of indication for integrated treatment.
The perceived relationship between SUD and PTSD is
an important factor in the administration of integrated
treatment. Further research into the relationship
between SUD and PTSD and its effect on treatment exe-
cution and treatment results is needed and can contrib-
ute to future treatment guidelines. Inpatient treatment
should be considered when patients need external sup-
port due to psychiatric and/or physical vulnerabilities.
For integrated treatment to be offered to all eligible pa-
tients however more training and sufficient inpatient
treatment options are necessary.
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